Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Neurology
What is your preferred approach to medication trials for diagnosis of nonconvulsive status epilepticus?
Related Questions
How do you approach use of newer anti-seizure medications for epilepsy patients on DOACs?
How do you transition from Levetiracetam to Brivaracetam, particularly at doses of 1500 mg BID or higher?
When do you use seizure prophylaxis in patients on clozapine?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
Do you use alcohol to trigger seizures in patients you suspect to have JME to confirm diagnosis?
Does persistent focal slowing without epileptiform discharges indicate increased seizure risk in patients without significant structural abnormalities?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
When would you start antiseizure medications in tuberous sclerosis before onset of seizures?
When do you target the thalamus for SEEG exploration or neuromodulation in patients with drug-resistant epilepsy?
When do you need to keep patients on anti-seizure medications when they had an acute symptomatic seizure in the setting of eclampsia, particularly if MgSO4 was given and there was no seizure recurrence?
